Nuvation Bio Inc.
HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS

Last updated:

Abstract:

Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.

Status:
Application
Type:

Utility

Filling date:

1 Jul 2020

Issue date:

1 Sep 2022